Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024
March 04 2024 - 7:00AM
Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a
clinical-stage biopharmaceutical company focused on advancing novel
oral therapies that address a broad range of inflammatory diseases
with significant unmet medical need, today announced that it will
host a virtual investor event on Monday, March 11, 2024 from 11:00
a.m. to 12:30 p.m. ET.
The event will provide key clinical updates on
our NLRP3 inhibitor portfolio, including topline results from the
Phase 2 trial of VTX2735 in CAPS and topline results from the Phase
1 trial of VTX3232 in healthy volunteers. We will also provide a
clinical update from the ongoing open-label extension of the VTX002
Phase 2 trial in ulcerative colitis.
To participate in the event, please dial (800) 343-4849 (U.S.)
or (203) 518-9848 (international) and reference passcode VTYX0311.
A live webcast will be available in the Investors section of the
Company’s website at www.ventyxbio.com. A recording of the webcast
will be available for thirty days following the call.
About Ventyx Biosciences
Ventyx is a clinical-stage biopharmaceutical
company focused on developing innovative oral medicines for
patients living with autoimmune and inflammatory disorders. We
believe our ability to efficiently discover and develop
differentiated drug candidates will allow us to address important
unmet medical need with novel oral therapies that can shift
immunology markets from injectable to oral drugs. Our current
pipeline includes internally discovered clinical programs targeting
TYK2, S1P1R and NLRP3, positioning us to become a leader in the
development of oral immunology therapies. Ventyx is headquartered
in San Diego, California. For more information about Ventyx, please
visit www.ventyxbio.com.
Investor Relations ContactPatti BankManaging
DirectorICR Westwicke(415) 513-1284IR@ventyxbio.com
Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
From Oct 2023 to Oct 2024